We are live on ! Find out more
JANX icon

Janux Therapeutics
JANX

46 hedge funds and large institutions have $542M invested in Janux Therapeutics in 2021 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 19 increasing their positions, 9 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

111% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 9

20% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 5

2.4% more ownership

Funds ownership: 63.68% → 66.08% (+2.4%)

2% more funds holding

Funds holding: 45 → 46 (+1)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

5% less capital invested

Capital invested by funds: $571M → $542M (-$29.6M)

Holders
46
Holders Change
+1
Holders Change %
+2.22%
% of All Funds
0.71%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
6
Increased
19
Reduced
9
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$28.8M
2
BlackRock
BlackRock
New York
+$4.33M
3
Cerity Partners
Cerity Partners
New York
+$3.16M
4
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale
Germany
+$943K
5
State Street
State Street
Massachusetts
+$774K

Top Sellers

Rank Fund Capital Flow
1
O
OrbiMed
New York
-$13.2M
2
SG Americas Securities
SG Americas Securities
New York
-$1.42M
3
LGM
Logos Global Management
California
-$1.3M
4
PPA
Parametric Portfolio Associates
Washington
-$1.28M
5
Janney Montgomery Scott
Janney Montgomery Scott
Pennsylvania
-$884K
Name Holding Trade Value Shares
Change 		Change in
Stake
Goldman Sachs
26
Goldman Sachs
New York
$291K +$309K +14,748 New
Morgan Stanley
27
Morgan Stanley
New York
$285K +$163K +7,777 +116%
JP Morgan Chase
28
JP Morgan Chase
New York
$262K +$143K +6,814 +105%
RhumbLine Advisers
29
RhumbLine Advisers
Massachusetts
$218K -$1.53K -73 -0.7%
CPIG
30
Chicago Partners Investment Group
Illinois
$188K +$40.3K +1,922 +20%
New York State Common Retirement Fund
31
New York State Common Retirement Fund
New York
$188K +$151K +7,221 +314%
Deutsche Bank
32
Deutsche Bank
Germany
$170K +$9.07K +433 +5%
Wells Fargo
33
Wells Fargo
California
$163K +$171K +8,149 +11,012%
Bank of America
34
Bank of America
North Carolina
$150K +$98.3K +4,691 +159%
California State Teachers Retirement System (CalSTRS)
35
California State Teachers Retirement System (CalSTRS)
California
$141K – – –
AIG
36
American International Group
New York
$139K -$4.42K -211 -3%
Allspring Global Investments
37
Allspring Global Investments
North Carolina
$105K +$112K +5,357 New
MIM
38
MetLife Investment Management
New Jersey
$105K – – –
Citigroup
39
Citigroup
New York
$94K +$63.5K +3,029 +173%
MLICM
40
Metropolitan Life Insurance Company (MetLife)
New York
$79.1K – – –
UBS Group
41
UBS Group
Switzerland
$73K +$3.88K +185 +5%
Royal Bank of Canada
42
Royal Bank of Canada
Ontario, Canada
$58K +$2.41K +115 +4%
TRCT
43
Tower Research Capital (TRC)
New York
$27K +$18.1K +862 +165%
Legal & General Group
44
Legal & General Group
United Kingdom
$24K – – –
AIP
45
Ameritas Investment Partners
Nebraska
$20K – – –
Daiwa Securities Group
46
Daiwa Securities Group
Japan
$2K +$2.54K +121 New
SG Americas Securities
47
SG Americas Securities
New York
– -$1.42M -65,414 Closed
PPA
48
Parametric Portfolio Associates
Washington
– -$1.28M -59,366 Closed
Janney Montgomery Scott
49
Janney Montgomery Scott
Pennsylvania
– -$884K -40,860 Closed
SO
50
STRS Ohio
Ohio
– -$64K -3,000 Closed
1
2
3

JANX Hedge Fund Activity: Q4 2021 in Review

46 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Janux Therapeutics (JANX) for Q4 2021, worth a combined $542M — down 5.2% from $571M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new JANX positions and 5 closed out — a net gain of 1 holder — while 19 added to existing stakes and 9 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $28.8M. The largest seller was OrbiMed, cutting an estimated $13.2M.

  • 46 institutional investors held Janux Therapeutics (JANX) as of Q4 2021, up from 45 in Q3 2021.
  • Funds reported $542M of Janux Therapeutics stock for Q4 2021, down 5.2% quarter-over-quarter.
  • 6 funds opened new Janux Therapeutics positions in Q4 2021 and 5 closed out, a net change of +1 holder.
  • The largest Janux Therapeutics buyer in Q4 2021 was Fidelity Investments, an estimated $28.8M added.
  • The largest Janux Therapeutics seller in Q4 2021 was OrbiMed, an estimated $13.2M sold.

Based on aggregated 13F filings for Q4 2021.